grant | 2025 - 2029
A moonshot to accelerate bench to bedside rare diseases precision medicines
WA State Government
Grant no. 22666.
grant | 2025 - 2025
Mini Brain Models of Childhood Neurological Disorders
Channel 7 Telethon Trust
Grant no. 22663.
grant | 2025 - 2029
Streamlining the development of antisense therapeutics for Western Australian children with rare genetic disorders
Stan Perron Foundation
Grant no. 22976.
grant | 2025 - 2028
Uncovering disease mechanisms and exploring therapies for muscular dystrophies
Perron Institute for Neurological and Translational Science (Australia, Nedlands) - WANRI
Grant no. 22917.
grant | 2024 - 2025
ASO-Mediated Therapeutic Intervention for Malan Syndrome (Year 2)
Malan Syndrome Foundation
Grant no. 21937.
grant | 2024 - 2026
Establishment of an early-stage clinical trial manufacturing enabling facility for small RNA therapeutics.
Western Australian Department of Health
Grant no. 22373.
grant | 2024 - 2024
Perron SPA Tooba Iqbal
Perron Institute for Neurological and Translational Science (Australia, Nedlands) - WANRI
Grant no. 22125.
grant | 2023 - 2027
An Innovative Approach to Modulate Alzheimers Disease Progression via Reduction of DYRK1A Activity Using Antisense Oligonucleotides.
Peacocke Foundation
Grant no. 22651.
grant | 2023 - 2026
Byron Kakulas Prestige Scholarships - Isabella Trew
Perron Institute for Neurological and Translational Science (Australia, Nedlands) - WANRI
Grant no. 21728.
grant | 2023 - 2027
CMMIT 2023-2027 Research Program
Perron Institute for Neurological and Translational Science
Grant no. 21394.
grant | 2023 - 2024
Led by Monash - Pre-clinical testing of novel inhaled RNA therapies for stability safety and effectiveness against SARS-CoV-2 to demonstrate proof of concept
General
Grant no. 20967.
grant | 2023 - 2024
NFIX upregulation validation in neuronally differentiated Malan patient-derived iPSC
RTW Charitable Foundation
Grant no. 21537.
grant | 2023 - 2023
Perron Institute - SPA Sarah Rea (Ext IRMA 19158)
Perron Institute for Neurological and Translational Science (Australia, Nedlands) - WANRI
Grant no. 21371.
grant | 2023 - 2024
Perron SPA Belinda Kaskow
Perron Institute for Neurological and Translational Science
Grant no. 21589.
grant | 2023 - 2025
Sarepta 2023 - 2025
General
Grant no. 21339.
grant | 2022 - 2025
A new substrate reduction strategy to treat multiple childhood dementias: Glucosylceramide synthase-targeting antisense oligonucleotides
National Health and Medical Research Council (Australia, Canberra) - NHMRC
Grant no. 21230.
grant | 2022 - 2024
A targeted therapy for juvenile-onset Parkinsons disease patients arising from PARK2 mutations using splice-switching antisense oligonucleotides
Perron Institute for Neurological and Translational Science (Australia, Nedlands) - WANRI
Grant no. 21283.
grant | 2022 - 2022
CMMIT 2022 Research Program
General
Grant no. 20729.
grant | 2022 - 2022
Development of novel oligonucleotide senotherapeutics
General
Grant no. 21099.
grant | 2022 - 2023
Development of novel oligonucleotide senotherapeutics
General
Grant no. 21360.
grant | 2022 - 2023
DYRK1A Restoration for Childhood Intellectual Diseases: A Genetic Balancing Act
Perron Institute for Neurological and Translational Science (Australia, Nedlands) - WANRI
Grant no. 21290.
grant | 2022 - 2024
Humanised Mouse Model of Malan Syndrome
RTW Charitable Foundation
Grant no. 20818.
grant | 2022 - 2023
Live-cell imaging for childhood diseases
Channel 7 Telethon Trust
Grant no. 20948.
grant | 2022 - 2022
Modification of Midkine expression (Extension)
Lyramid Ltd
Grant no. 20895.
grant | 2022 - 2024
RAGE against Sepsis
Channel 7 Telethon Trust
Grant no. 21289.
grant | 2022 - 2026
UNSW Led - Advancing congenital and childhood-onset muscle disease diagnosis and treatment - a cross-disciplinary Australian collaboration
General
Grant no. 21189.
grant | 2021 - 2022
Antisense Oligomer-Mediated Therapeutic Intervention for Malan Syndrome
Malan Syndrome Foundation
Grant no. 20124.
grant | 2021 - 2021
Development of novel oligonucleotide senotherapeutics
General
Grant no. 20233.
grant | 2021 - 2022
Development of novel oligonucleotide senotherapeutics (Extension IRMA 20233)
General
Grant no. 20821.
grant | 2021 - 2023
led by SKINRI - Single blinded randomised control trial evaluating DACC impregnated dRessings for the prevention of Surgical siTe infection in at risk patients uNdergoing Abdominal surgery: the CRISTINA-A trial
General
Grant no. 20506.
grant | 2021 - 2022
Lyramid: Modification of Midkine expression
Lyramid Ltd
Grant no. 20467.
grant | 2021 - 2022
Treatments for those who have none
Channel 7 Telethon Trust
Grant no. 20611.
grant | 2020 - 2021
2020 Equipment Grant
General
Grant no. 20041.
grant | 2020 - 2021
CMMIT research program on new drugs and diagnostics and clinical research translation
General
Grant no. 19780.
grant | 2020 - 2021
Converting astrocytes into dopaminergic neurons using splice-switching antisense oligomers: a potential treatment for Parkinsons disease
Perron Institute for Neurological and Translational Science (Australia, Nedlands) - WANRI
Grant no. 19864.
grant | 2020 - 2021
Guidelines for exercise in multiple sclerosis (GEMS) effectiveness and clinical translation
General
Grant no. 19722.
grant | 2020 - 2021
Hudson Institute of Medical Research led - A drug to stop brain cell death in Parkinson's disease
General
Grant no. 19487.
grant | 2020 - 2023
led by Monash - Coronavirus Research Response - 2020 Antiviral Development for COVID-19
General
Grant no. 19661.
grant | 2020 - 2023
Perron Institute & MU Contribution & Revenue Sharing Agreement
General
Grant no. 19116.
grant | 2020 - 2023
Perron Sponsored Position - Dr Sarah Rea
General
Grant no. 19158.
grant | 2020 - 2025
Perron Sponsored Position Dr Tamer Kosbar
General
Grant no. 19077.
grant | 2020 - 2023
Pre-clinical development of a SOD1 genetic therapy in sporadic ALS: enabling investigational new drug submission
General
Grant no. 19597.
grant | 2020 - 2021
Project SCORE Music and Walking for Neurology: the effect of auditory cues and music during walking on movement quality and motivation in persons with multiple sclerosis.
General
Grant no. 19689.
grant | 2019 - 2020
2019 Equipment Grant GNT9000609
General
Grant no. 19387.
grant | 2019 - 2019
Exon skipping strategy as a treatment for recessive Ullrich Congenital Muscular Dystrophy
The Orphan Disease Center
Grant no. 18607.
grant | 2019 - 2023
Perron Sponsored Position - Sulev Koks
General
Grant no. 18427.
grant | 2019 - 2019
Sarepta First Amendment - 2019 invoicing
General
Grant no. 18944.
grant | 2019 - 2021
University of Melbourne led - Developing a novel class of therapeutics for muscle wasting and frailty
General
Grant no. 18381.
grant | 2018 - 2019
2018 Student travel awards
General
Grant no. 18512.
grant | 2018 - 2019
Antisense mediated inhibition of PCSK9 activity: potential therapy for familial hypercholesterolemia
Perron Institute for Neurological and Translational Science (Australia, Nedlands) - WANRI
Grant no. 18588.
grant | 2018 - 2020
Enid Home Bequest Scholarship - Bal Poudel
General
Grant no. 18128.
grant | 2018 - 2019
Equipment Grant 2018 GNT9000563
General
Grant no. 18731.
grant | 2018 - 2019
Lions Eye Institute led - Stargardt macular degeneration: finding new genetic mutations
General
Grant no. 18496.
grant | 2018 - 2021
Perron Scholarship - Di Huang
General
Grant no. 18121.
grant | 2018 - 2020
Rita Mejzini - Perron Institute Prestige Scholarship
General
Grant no. 18179.
grant | 2018 - 2021
Targeted alternative splicing: a common therapeutic platform to treat inherited diseases
General
Grant no. 17610.
grant | 2018 - 2019
To establish animal (Bovine Pig etc) myoblast culture for the potential growth of a cultured biotech burger
General
Grant no. 18595.
grant | 2018 - 2018
To experiment with the use of Nanollose material as a scaffold for the growth of human or animal cells
General
Grant no. 18594.
grant | 2017 - 2018
Equipment Grant 2017
General
Grant no. 18046.
grant | 2017 - 2019
Lions Eye Institute Led - Establishing a centre of research excellence in juvenile macular disease
General
Grant no. 17672.
grant | 2017 - 2019
Mapping functional domains of the dystrophin protein based on exon structure
General
Grant no. 17132.
grant | 2017 - 2018
Mapping redundant exons through the generation of animal models of human disease
General
Grant no. 17993.
grant | 2017 - 2019
Monash Led - RAGE and ACE2 shedding as therapeutic targets in diabetes and cardiovascular disease
General
Grant no. 17543.
grant | 2017 - 2022
Perron Scholarship - Sarah Leishman
General
Grant no. 17977.
grant | 2017 - 2022
Reimbursement Grant for general research-related expenditure
General
Grant no. 18090.
grant | 2017 - 2018
Student travel awards
General
Grant no. 18078.
grant | 2016 - 2016
2016 NHMRC Equipment Grant
General
Grant no. 17302.
grant | 2016 - 2017
Ad-hoc consultancy
General
Grant no. 17321.
grant | 2016 - 2016
Antisense oligomer induced splice intervention targeting ITGA4 and LINGO1 as a combined treatment for multiple sclerosis.
Multiple Sclerosis Research Australia (Australia, North Sydney)
Grant no. 16641.
grant | 2016 - 2017
Targeted delivery of splice switching oligonucleotides to enhance treatment of Duchenne muscular dystrophy
General
Grant no. 16784.
grant | 2015 - 2015
Antisense oligonucleotides for the treatment of disorders of surfactant metabolism causing childhood interstitial lung disease.
General
Grant no. 16477.
grant | 2015 - 2016
Correlation Study: PMO Relative Activity Ranking in DMD Patient Myoblasts and Normal Myoblasts - First extension
General
Grant no. 16657.
grant | 2015 - 2016
NHMRC Equipment Grant 2015
General
Grant no. 16669.
grant | 2015 - 2019
Sarepta Master Agreement
General
Grant no. 16711.
grant | 2015 - 2017
Scoping new exon skipping applications.
Sarepta Therapeutics (United States, Cambridge)
Grant no. 17048.
grant | 2015 - 2016
Splice correction as a treatment for rare diseases
General
Grant no. 15734.
grant | 2015 - 2015
UWA led - High resolution mass spectrometry for metabolomics and proteomics research
General
Grant no. 16302.
grant | 2014 - 2014
2014 NHMRC Equipment Grant
General
Grant no. 16613.
grant | 2014 - 2015
Developing a splice switching therapy to correct a common defect in GAA causing adult onset Glycogen storage disease II
General
Grant no. 15745.
grant | 2014 - 2016
UWA Lead - The L-type calcium channel as a reporter of successful morpholino oligomer therapy in treatment of Duchenne Muscular Dystrophy cardimyopathy
General
Grant no. 15846.
grant | 2013 - 2015
Antisense oligomer induced suppression of target genes implicated in Multiple Sclerosis
General
Grant no. 15464.
grant | 2013 - 2016
Oligomer Design & Validation for DMD: Quantum Improvements in Exon Skipping
General
Grant no. 15417.
grant | 2013 - 2015
Optimization of splice switching therapies to treat Duchenne muscular dystrophy
General
Grant no. 15063.